Scholarly Index
Anna M. Czarnecka
The Maria Sklodowska-Curie National Research Institute of Oncology; 6,153 total citations; 317 total publications; best world rank #25
The Maria Sklodowska-Curie National Research Institute of Oncology
6,153Total citations
317Total publications
41H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 757 | PL 2 | 97.07 |
| Renal and related cancers | Lifetime | 978 | PL 4 | 96.00 |
| Vascular Tumors and Angiosarcomas | Lifetime | 591 | PL 3 | 93.42 |
| Melanoma and MAPK Pathways | Lifetime | 876 | PL 5 | 92.17 |
| Tuberous Sclerosis Complex Research | Lifetime | 441 | PL 11 | 86.39 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 66 | PL 2 | 98.22 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 25 | PL 2 | 96.34 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 162 | PL 4 | 91.50 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 255 | PL 2 | 92.63 |
| Soft tissue tumor case studies | 2021-2025 | 68 | PL 2 | 88.78 |
| Melanoma and MAPK Pathways | 2021-2025 | 201 | PL 2 | 90.03 |
| Cardiac tumors and thrombi | 2021-2025 | 457 | PL 6 | 78.06 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 115 | PL 3 | 77.61 |
| Cancer and Skin Lesions | 2021-2025 | 475 | PL 14 | 74.74 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 703 | PL 19 | 78.23 |
| Ocular Oncology and Treatments | 2021-2025 | 797 | PL 12 | 66.60 |